Your browser doesn't support javascript.
loading
Acute cytomegalovirus hepatitis in an immunocompetent patient: A case report.
Wang, Jack P; Lin, Bou-Zenn; Lin, Chih-Lin; Chen, Kuan-Yang; Lin, Tsung-Jung.
Affiliation
  • Wang JP; Department of Gastroenterology, Taipei City Hospital, Taipei City 10629, Taiwan.
  • Lin BZ; Department of Gastroenterology, Taipei City Hospital, Taipei City 10629, Taiwan.
  • Lin CL; Department of Gastroenterology, Taipei City Hospital, Taipei City 10629, Taiwan.
  • Chen KY; Department of Gastroenterology, Taipei City Hospital, Taipei City 10629, Taiwan.
  • Lin TJ; Department of Gastroenterology, Taipei City Hospital, Taipei City 10629, Taiwan. dab70@tpech.gov.tw.
World J Clin Cases ; 10(34): 12605-12609, 2022 Dec 06.
Article in En | MEDLINE | ID: mdl-36579114
ABSTRACT

BACKGROUND:

Cytomegalovirus (CMV) infection is usually subclinical and asymptomatic in the healthy population, whereas severe complications occur in immunocompromised patients. CASE

SUMMARY:

In this case report, we described a rare case of acute CMV hepatitis in a 35-year-old male immunocompetent patient who presented with a history of week-long intermittent fever with nonspecific constitutional symptoms. Acute hepatitis was suspected according to the initial serological tests. After ruling out other etiologies, including viral hepatitis A, B, C, drug, alcohol, autoimmune, and Wilson disease, acute CMV hepatitis was diagnosed based on positive CMV IgM and DNA quantitative tests. Because there was no any local acute hepatitis E reported in Taiwan, so hepatitis E was not checked. The patient recovered both clinically and serologically with symptomatic management and without antiviral therapy within 12 days from the onset of symptom.

CONCLUSION:

In conclusion, a diagnosis of CMV infection should be considered when nonspecific prodromal symptoms occur in acute hepatitis with an uncertain etiology. Antiviral therapy should not be used in immunocompetent patient who had no decompensation of the liver, such as this patient. Widely available noninvasive tests for CMV can facilitate early diagnosis if used appropriately. Harm-benefit analysis is essential before using antiviral therapy in immunocompetent patients.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Screening_studies Language: En Journal: World J Clin Cases Year: 2022 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Screening_studies Language: En Journal: World J Clin Cases Year: 2022 Document type: Article Affiliation country: